Dark Forest Capital Management’s Cogent Biosciences COGT Stock Holding History

Dark Forest Capital Management’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,391	Closed	-$592K	–	835
2026 Q1	$592K	Buy	+15,391	New	+$568K	0.05%	517
2025 Q2	–	Sell	-28,982	Closed	-$174K	–	1233
2025 Q1	$174K	Buy	+28,982	New	+$227K	0.01%	1156
2024 Q4	–	Sell	-12,382	Closed	-$134K	–	1001
2024 Q3	$134K	Buy	+12,382	New	+$121K	0.02%	910
2024 Q2	–	Sell	-16,744	Closed	-$113K	–	693
2024 Q1	$113K	Buy	+16,744	New	+$104K	0.02%	659

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dark Forest Capital Management's COGT Position: Q2 2026 in Review

Dark Forest Capital Management sold out of Cogent Biosciences (COGT) in Q2 2026, closing a stake of 15,391 shares — an estimated $592K sold.

Dark Forest Capital Management first reported a position in COGT in Q1 2024 and held it in 4 quarters. The position peaked at $592K in Q1 2026. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

Dark Forest Capital Management reported no remaining Cogent Biosciences position as of Q2 2026 after selling out during the quarter.
Dark Forest Capital Management sold 15,391 Cogent Biosciences shares in Q2 2026, an estimated $592K.
Dark Forest Capital Management first reported a position in Cogent Biosciences in Q1 2024 and held it in 4 quarters.
Dark Forest Capital Management's Cogent Biosciences position peaked at $592K in Q1 2026.
324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.